Press enter or spacebar to select a desired language.
Gas and Oil
Powered by EBSCO
Press enter or spacebar to select a desired language.

RSS Items

2721 - 2730 of 71479 results found

A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial

Date
Monday, November 06, 2023 - 4:00 AM
Description
CONCLUSIONS: The data suggest mirtazapine is not clinically or cost-effective (compared to placebo) for agitation in dementia. There is little reason to recommend mirtazapine for people with dementia with agitation.